Early Access — free while we kick the tires
EdgarHawk

Huh Yong-Jun

Director

Director
1 filing analyzed · 1 company · Latest 2024-07-22

Companies

Company Buys Sells Direction
Artiva Biotherapeutics, Inc. ARTV 8 0 Net buying

Activity

July 2024
high
Buy
2,083,332 shares
$24,999,984
Significance 7/10

Director Huh Yong-Jun purchases 2,083,332 shares for $24,999,984.00 at $12.00 in two transactions

Director Huh Yong-Jun executed two purchases totaling 2,083,332 shares for $24,999,984.00 at $12.00 per share on 2024-07-22. This $25.0M purchase is noteworthy given the company's recent listing status (2 trading days old), where the current market price of $11.77 sits slightly below the transaction price. The transaction involves a conversion of derivative securities, meaning the 1,260,512 shares held post-transaction represents only Table I holdings and does not capture the insider's full derivative position. A cluster pattern is present, with 4 other insiders also purchasing within the past 14 days, suggesting coordinated capital deployment during the early public trading period.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access